Recurrent Submandibular Sialadenitis With Associated Submandibular Lymphadenopathy Secondary to Iodinated Contrast: A

Naishal Mandal1, Majd Hasan1, Shaza Mohammed1

  • 1Internal Medicine, Hurley Medical Center/Michigan State University (MSU) College of Human Medicine, Flint, USA.

Cureus
|May 29, 2026
PubMed

Iodinated contrast media are essential diagnostic tools widely used in radiographic and computed tomography (CT) examinations, with millions of procedures performed annually. Although generally well tolerated, these agents can, rarely, cause adverse reactions, including hypersensitivity reactions, acute kidney injury, and contrast-induced sialadenitis (iodide mumps). Contrast-induced sialadenitis is an uncommon, benign reaction to iodinated contrast media that most frequently involves the parotid glands and is likely underrecognized. Submandibular gland involvement with associated cervical lymphadenopathy is particularly rare and may mimic infectious or obstructive salivary gland pathology. We report a case of a 64-year-old woman who developed acute bilateral submandibular swelling and pain three to four hours after iodinated contrast administration for a CT performed to evaluate acute abdominal pain. The patient had a history of similar, self-limited episodes following prior contrast exposure. Physical examination revealed diffuse submental and submandibular swelling with mild tenderness but no signs of infection or airway compromise. Ultrasound demonstrated bilateral submandibular gland enlargement with heterogeneous echotexture, increased vascularity, and reactive cervical lymphadenopathy. Based on the temporal relationship to contrast exposure, prior similar episodes, absence of infectious features, and supportive imaging findings, a diagnosis of contrast-induced submandibular sialadenitis was made. Symptoms improved rapidly with conservative management and resolved within two days. This case highlights the importance of recognizing contrast-induced submandibular sialadenitis as a rare but benign and self-limiting condition. Awareness of this entity can help clinicians avoid unnecessary antibiotics, corticosteroids, and extensive diagnostic workup. Proper recognition and documentation are also important for counseling patients about future contrast exposure and considering alternative imaging modalities when appropriate.

Related Concept Videos

Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...